US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 35.510
  • +0.140+0.40%
Trading Nov 15 11:20 ET
2.91BMarket Cap-17755P/E (TTM)

Verona Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-392.30%-62.66M
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
60.16%-5.78M
-80.01%-59.86M
55.33%-7.74M
Net income from continuing operations
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
Operating gains losses
-245.75%-1.48M
590.27%3.63M
123.50%219K
-140.28%-1.87M
51.23%-1.21M
-73.71%1.01M
-134.63%-740K
-183.29%-932K
126.59%4.63M
84.28%-2.47M
Depreciation and amortization
71.61%266K
71.97%270K
67.52%263K
6.45%677K
37.75%208K
-1.27%155K
-4.85%157K
-3.68%157K
1.11%636K
-6.79%151K
Other non cash items
12,406.25%6M
385.42%233K
89.01%172K
18.09%222K
29.63%35K
-11.11%48K
-9.43%48K
68.52%91K
-21.34%188K
-49.06%27K
Change In working capital
-641.60%-32.14M
299.54%34.01M
-1.13%7.27M
-29.43%-13.9M
-75.40%124K
53.52%-4.33M
-138.06%-17.04M
40.34%7.36M
-179.87%-10.74M
-97.08%504K
-Change in receivables
-2,846.77%-8.52M
302.79%7.79M
74.71%-585K
-127.85%-1.1M
-107.91%-1.03M
111.69%310K
139.59%1.93M
-46.58%-2.31M
157.25%3.96M
21.61%13.08M
-Change in prepaid assets
-3.81%-2.53M
-371.51%-1.81M
-100.53%-5K
-172.69%-1.12M
-133.29%-285K
-277.18%-2.44M
119.14%667K
-66.39%938K
206.99%1.54M
-67.51%856K
-Change in payables and accrued expense
440.34%5.97M
145.87%7.37M
-19.57%6.77M
29.73%-10.9M
89.49%-1.51M
74.98%-1.76M
-1,557.35%-16.06M
78.03%8.42M
-172.49%-15.51M
-359.40%-14.33M
-Change in other current assets
-255.33%-867K
73.15%-907K
-30.84%942K
158.64%777K
7,492.50%3.04M
80.03%-244K
-1,158.93%-3.38M
394.81%1.36M
-69.22%-1.33M
103.95%40K
-Change in other current liabilities
-10,472.95%-21.89M
10,623.41%21.57M
114.18%149K
-358.93%-1.55M
-110.20%-88K
-210.70%-207K
3.30%-205K
-339.75%-1.05M
179.65%599K
237.20%863K
Cash from discontinued investing activities
Operating cash flow
-392.30%-62.66M
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
60.16%-5.78M
-80.01%-59.86M
55.33%-7.74M
Investing cash flow
Cash flow from continuing investing activities
0
-29K
-16K
0
0
0
0
0
-141.67%-29K
0
Net PPE purchase and sale
--0
---29K
---16K
--0
--0
--0
--0
--0
-141.67%-29K
--0
Cash from discontinued investing activities
Investing cash flow
--0
---29K
---16K
--0
--0
--0
--0
--0
-141.67%-29K
--0
Financing cash flow
Cash flow from continuing financing activities
-14,864.58%-7.09M
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
9,560.74%68.69M
2,402.08%140.82M
390.12%2.61M
Net issuance payments of debt
--100M
--70.24M
--0
674.16%38.71M
474.24%28.71M
--0
--0
--10M
--5M
--5M
Net common stock issuance
--0
--0
--0
-62.01%56.91M
--0
--0
--47K
84,768.66%56.86M
20,336.15%149.8M
--0
Proceeds from stock option exercised by employees
7,541.67%3.67M
--0
-55.34%816K
42.06%1.95M
-100.30%-3K
-87.06%48K
--77K
--1.83M
--1.37M
--1M
Net other financing activities
---110.76M
--96.59M
---3.94M
69.40%-4.7M
----
----
----
----
-124.10%-15.35M
-275.92%-3.39M
Cash from discontinued financing activities
Financing cash flow
-14,864.58%-7.09M
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
9,560.74%68.69M
2,402.08%140.82M
390.12%2.61M
Net cash flow
Beginning cash position
49.45%404.6M
-12.54%254.88M
19.29%271.77M
53.54%227.83M
11.08%257.37M
142.78%270.73M
119.50%291.42M
53.54%227.83M
-21.07%148.38M
39.12%231.7M
Current changes in cash
-450.06%-69.74M
806.57%149.7M
-126.63%-16.75M
-47.30%42.65M
365.61%13.61M
-110.43%-12.68M
-4.70%-21.19M
512.80%62.9M
305.49%80.93M
71.88%-5.12M
Effect of exchange rate changes
273.46%1.18M
-96.79%16K
-120.58%-141K
187.70%1.3M
-36.32%796K
48.84%-682K
148.97%499K
281.22%685K
-563.68%-1.48M
2,055.17%1.25M
End cash Position
30.57%336.04M
49.45%404.6M
-12.54%254.88M
19.29%271.77M
19.29%271.77M
11.08%257.37M
142.78%270.73M
119.50%291.42M
53.54%227.83M
53.54%227.83M
Free cash flow
-392.30%-62.66M
19.61%-17.13M
-135.66%-13.63M
16.14%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.03%-21.31M
60.16%-5.78M
-80.04%-59.89M
55.33%-7.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -392.30%-62.66M 19.75%-17.1M -135.39%-13.61M 16.10%-50.22M -34.43%-10.4M 29.67%-12.73M -9.19%-21.31M 60.16%-5.78M -80.01%-59.86M 55.33%-7.74M
Net income from continuing operations -192.52%-42.96M -704.30%-70.84M -54.06%-25.79M 20.86%-54.37M -35.22%-14.13M 6.14%-14.69M 50.43%-8.81M 32.59%-16.74M -23.63%-68.7M 55.07%-10.45M
Operating gains losses -245.75%-1.48M 590.27%3.63M 123.50%219K -140.28%-1.87M 51.23%-1.21M -73.71%1.01M -134.63%-740K -183.29%-932K 126.59%4.63M 84.28%-2.47M
Depreciation and amortization 71.61%266K 71.97%270K 67.52%263K 6.45%677K 37.75%208K -1.27%155K -4.85%157K -3.68%157K 1.11%636K -6.79%151K
Other non cash items 12,406.25%6M 385.42%233K 89.01%172K 18.09%222K 29.63%35K -11.11%48K -9.43%48K 68.52%91K -21.34%188K -49.06%27K
Change In working capital -641.60%-32.14M 299.54%34.01M -1.13%7.27M -29.43%-13.9M -75.40%124K 53.52%-4.33M -138.06%-17.04M 40.34%7.36M -179.87%-10.74M -97.08%504K
-Change in receivables -2,846.77%-8.52M 302.79%7.79M 74.71%-585K -127.85%-1.1M -107.91%-1.03M 111.69%310K 139.59%1.93M -46.58%-2.31M 157.25%3.96M 21.61%13.08M
-Change in prepaid assets -3.81%-2.53M -371.51%-1.81M -100.53%-5K -172.69%-1.12M -133.29%-285K -277.18%-2.44M 119.14%667K -66.39%938K 206.99%1.54M -67.51%856K
-Change in payables and accrued expense 440.34%5.97M 145.87%7.37M -19.57%6.77M 29.73%-10.9M 89.49%-1.51M 74.98%-1.76M -1,557.35%-16.06M 78.03%8.42M -172.49%-15.51M -359.40%-14.33M
-Change in other current assets -255.33%-867K 73.15%-907K -30.84%942K 158.64%777K 7,492.50%3.04M 80.03%-244K -1,158.93%-3.38M 394.81%1.36M -69.22%-1.33M 103.95%40K
-Change in other current liabilities -10,472.95%-21.89M 10,623.41%21.57M 114.18%149K -358.93%-1.55M -110.20%-88K -210.70%-207K 3.30%-205K -339.75%-1.05M 179.65%599K 237.20%863K
Cash from discontinued investing activities
Operating cash flow -392.30%-62.66M 19.75%-17.1M -135.39%-13.61M 16.10%-50.22M -34.43%-10.4M 29.67%-12.73M -9.19%-21.31M 60.16%-5.78M -80.01%-59.86M 55.33%-7.74M
Investing cash flow
Cash flow from continuing investing activities 0 -29K -16K 0 0 0 0 0 -141.67%-29K 0
Net PPE purchase and sale --0 ---29K ---16K --0 --0 --0 --0 --0 -141.67%-29K --0
Cash from discontinued investing activities
Investing cash flow --0 ---29K ---16K --0 --0 --0 --0 --0 -141.67%-29K --0
Financing cash flow
Cash flow from continuing financing activities -14,864.58%-7.09M 134,441.94%166.83M -104.55%-3.12M -34.05%92.87M 818.59%24.01M -99.97%48K 118.00%124K 9,560.74%68.69M 2,402.08%140.82M 390.12%2.61M
Net issuance payments of debt --100M --70.24M --0 674.16%38.71M 474.24%28.71M --0 --0 --10M --5M --5M
Net common stock issuance --0 --0 --0 -62.01%56.91M --0 --0 --47K 84,768.66%56.86M 20,336.15%149.8M --0
Proceeds from stock option exercised by employees 7,541.67%3.67M --0 -55.34%816K 42.06%1.95M -100.30%-3K -87.06%48K --77K --1.83M --1.37M --1M
Net other financing activities ---110.76M --96.59M ---3.94M 69.40%-4.7M ---- ---- ---- ---- -124.10%-15.35M -275.92%-3.39M
Cash from discontinued financing activities
Financing cash flow -14,864.58%-7.09M 134,441.94%166.83M -104.55%-3.12M -34.05%92.87M 818.59%24.01M -99.97%48K 118.00%124K 9,560.74%68.69M 2,402.08%140.82M 390.12%2.61M
Net cash flow
Beginning cash position 49.45%404.6M -12.54%254.88M 19.29%271.77M 53.54%227.83M 11.08%257.37M 142.78%270.73M 119.50%291.42M 53.54%227.83M -21.07%148.38M 39.12%231.7M
Current changes in cash -450.06%-69.74M 806.57%149.7M -126.63%-16.75M -47.30%42.65M 365.61%13.61M -110.43%-12.68M -4.70%-21.19M 512.80%62.9M 305.49%80.93M 71.88%-5.12M
Effect of exchange rate changes 273.46%1.18M -96.79%16K -120.58%-141K 187.70%1.3M -36.32%796K 48.84%-682K 148.97%499K 281.22%685K -563.68%-1.48M 2,055.17%1.25M
End cash Position 30.57%336.04M 49.45%404.6M -12.54%254.88M 19.29%271.77M 19.29%271.77M 11.08%257.37M 142.78%270.73M 119.50%291.42M 53.54%227.83M 53.54%227.83M
Free cash flow -392.30%-62.66M 19.61%-17.13M -135.66%-13.63M 16.14%-50.22M -34.43%-10.4M 29.67%-12.73M -9.03%-21.31M 60.16%-5.78M -80.04%-59.89M 55.33%-7.74M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data